A phase I/II study of nintedanib and capecitabine for refractory metastatic colorectal cancer.

Patrick M BolandJohn M L EbosKristopher AttwoodMichalis MastriChristos FountzilasRenuka V IyerChristopher BankerAndrew K L GoeyRobert BiesWen Wee MaMarwan G Fakih

Published in: JNCI cancer spectrum (2024)

NCT02393755.

Keyphrases

metastatic colorectal cancer
idiopathic pulmonary fibrosis
randomized controlled trial
clinical trial
phase ii study
rheumatoid arthritis
study protocol
metastatic breast cancer
phase iii